Skip to main content
NANOSONICS LIMITED logo

NANOSONICS LIMITED — Investor Relations & Filings

Ticker · NAN ISIN · AU000000NAN9 LEI · 549300XUBCM70BRANN81 ASX Manufacturing
Open in API
Filings indexed 1,048 across all filing types
Latest filing 2012-07-24 Director's Dealing
Country AU Australia
Listing ASX NAN

About NANOSONICS LIMITED

https://www.nanosonics.com.au

Nanosonics Limited is a medical technology company specializing in the development and commercialization of infection prevention solutions. The company's flagship product, the trophon system, provides automated high-level disinfection (HLD) for ultrasound probes. Utilizing a proprietary hydrogen peroxide mist technology, the trophon device ensures consistent and effective disinfection of both the probe handle and shaft, addressing the risks of cross-contamination in clinical settings. The system is designed to integrate into diagnostic workflows, offering a faster and more environmentally sustainable alternative to traditional manual chemical soaking methods. Nanosonics continues to expand its portfolio with digital traceability tools and audit-ready reporting software to enhance compliance and patient safety across global healthcare facilities.

Recent filings

Filing Released Lang Actions
Appendix 3Y 3 pages 243.0KB
Director's Dealing Classification · 100% confidence The document is titled 'Appendix 3Y Change of Director’s Interest Notice' and contains detailed information about changes in a director's relevant interests in securities, including the number of shares held before and after the change, the nature of the change, and dates. It references ASX listing rules and the Corporations Act, indicating it is a regulatory filing related to insider trading or director shareholding disclosures. The document length is 3820 characters, which is relatively short and focused solely on director's share transactions. This matches the definition of 'Director's Dealing' filings, which report personal share transactions by company directors and executives (insider trades). Therefore, the correct classification is DIRS.
2012-07-24 English
Appendix 3B 6 pages 205.9KB
Share Issue/Capital Change Classification · 100% confidence The document is an official announcement from Nanosonics Limited regarding the issuance of shares and lapse of options under a Share Purchase Plan. It includes detailed information about the number of shares issued, the exercise price, and the purpose of the issue. The document also contains an Appendix 3B, which is a standard form used in Australian securities regulation to announce new issues of securities and apply for quotation on the ASX. The content focuses on share issuance, option lapses, and compliance with relevant sections of the Corporations Act. There is no financial performance data, management discussion, or audit information. The document is not a full financial report but a regulatory announcement about capital changes. Therefore, the appropriate classification is Share Issue/Capital Change (SHA). The document length (10,400 characters) and detailed content confirm it is not merely a brief announcement or a certification but a substantive filing about share issuance.
2012-07-19 English
Nanosonics issues Convertible Notes 19 pages 225.7KB
Capital/Financing Update Classification · 95% confidence The document is a detailed announcement from Nanosonics Limited regarding the issuance of convertible notes, including terms, background, purpose, and pro-forma financial effects. It includes a pro-forma statement of financial position and detailed capital structure impact analysis. The document is not a full financial report like an Annual Report (10-K) or Interim Report (IR), nor is it a simple announcement of a report publication. It is a capital/financing update describing a specific fundraising event and its financial implications. The presence of detailed financial data related to the convertible notes issuance and capital structure changes confirms it is a Capital/Financing Update (CAP).
2012-06-27 English
GE makes strategic investment in Nanosonics 4 pages 339.0KB
Capital/Financing Update Classification · 100% confidence The document is an announcement dated 25 June 2012 from Nanosonics Limited regarding a strategic investment by GE through the subscription of convertible notes worth $7.5 million. It details the terms of the convertible notes, including conversion price, interest, maturity, and shareholder approval requirements. The content focuses on financing activity, specifically the issuance of convertible notes and related agreements. There is no indication that this is a full financial report, audit, or earnings release. The document is not a regulatory certification or a brief announcement of a report publication. It clearly fits the category of a capital/financing update as it provides detailed information about a financing transaction and capital structure changes. Therefore, the appropriate classification is Capital/Financing Update (CAP).
2012-06-24 English
GE extends strategic relationship with Nanosonics 4 pages 151.5KB
Capital/Financing Update Classification · 95% confidence The document is a press release announcing GE's $7.5 million investment in Nanosonics to extend their strategic relationship. It discusses the business collaboration, product development, and market impact but does not contain financial statements, detailed financial performance data, or regulatory filing information. It is not an earnings release, annual report, or any formal regulatory filing. The document is a corporate announcement about a capital investment and strategic partnership, which fits best under Capital/Financing Update (CAP). The document length is sufficient and contains substantive content about the financing activity, not just a brief mention or report publication announcement.
2012-06-24 English
Extension of SPP Closing Date 1 page 142.6KB
Capital/Financing Update Classification · 100% confidence The document is a short announcement from Nanosonics Limited regarding the extension of the closing date for a Share Purchase Plan (SPP). It provides updated key dates and confirms that the terms of the SPP remain unchanged. There is no financial data, detailed report, or regulatory certification included. The document is clearly an update on a capital raising activity (share purchase plan) and not a full report or financial statement. Given the content and length (1190 characters), this fits the category of a Capital/Financing Update (CAP).
2012-06-17 English

Browse filings by year

20 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.